Pfizer Recalls Milrinone Lactate Injection Bags Due to Sterility Concerns
Pfizer is recalling 58,200 bags of Milrinone Lactate Injection in 5% Dextrose due to a lack of assurance of sterility and potential for bag leaks.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Pfizer Inc. is recalling 58,200 bags of Milrinone Lactate Injection 200 mcg (0.2 mg)/mL in 5% Dextrose Injection 40 mg/200 mL. The product is identified by NDC 0409-2776-02 and is available in 200 mL bags. The recall covers specific lots: 86-615-KL (Exp. 1FEB2020), 87-701-KL (Exp. 1MAR2020), and 90-114-KL (Exp. 1JUN2020).
The recall was initiated due to a lack of assurance of sterility, as the bags have the potential to leak. This defect could compromise the sterility of the medication, which is a critical safety requirement for intravenous injections.
The affected product was distributed in the United States, Puerto Rico, and Guam. Healthcare providers and facilities should discontinue use of the recalled lots and contact Pfizer for further instructions or returns.
The recalled product
- Product
- Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection 40 mg/200 mL, 200 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-02, Barcode (01)00304092776028.
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable Medication
- Affected units
- 58,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #s: 86-615-KL
- Exp. 1FEB2020
- 87-701-KL
- Exp. 1MAR2020
- 90-114-KL
- Exp. 1JUN2020
Distribution
Part of a larger recall action
This product is one of 2 recalled by Pfizer Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29